These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18671217)

  • 1. Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors.
    Pettersson S; Pérez-Nueno VI; Ros-Blanco L; Puig de La Bellacasa R; Rabal MO; Batllori X; Clotet B; Clotet-Codina I; Armand-Ugón M; Esté J; Borrell JI; Teixidó J
    ChemMedChem; 2008 Oct; 3(10):1549-57. PubMed ID: 18671217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
    Gerlach LO; Skerlj RT; Bridger GJ; Schwartz TW
    J Biol Chem; 2001 Apr; 276(17):14153-60. PubMed ID: 11154697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100.
    Labrosse B; Brelot A; Heveker N; Sol N; Schols D; De Clercq E; Alizon M
    J Virol; 1998 Aug; 72(8):6381-8. PubMed ID: 9658078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
    Rosenkilde MM; Gerlach LO; Hatse S; Skerlj RT; Schols D; Bridger GJ; Schwartz TW
    J Biol Chem; 2007 Sep; 282(37):27354-27365. PubMed ID: 17599916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
    Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
    J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel monocyclam derivatives as HIV entry inhibitors: Design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 co-receptor.
    Pettersson S; Pérez-Nueno VI; Mena MP; Clotet B; Esté JA; Borrell JI; Teixidó J
    ChemMedChem; 2010 Aug; 5(8):1272-81. PubMed ID: 20533501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Struyf S; Witvrouw M; Schols D; De Clercq E
    J Med Chem; 1999 Sep; 42(19):3971-81. PubMed ID: 10508445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists.
    De Clercq E
    Mol Pharmacol; 2000 May; 57(5):833-9. PubMed ID: 10779364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100.
    De Clercq E
    Mini Rev Med Chem; 2005 Sep; 5(9):805-24. PubMed ID: 16178723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor.
    Rosenkilde MM; Gerlach LO; Jakobsen JS; Skerlj RT; Bridger GJ; Schwartz TW
    J Biol Chem; 2004 Jan; 279(4):3033-41. PubMed ID: 14585837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor.
    Esté JA; Cabrera C; De Clercq E; Struyf S; Van Damme J; Bridger G; Skerlj RT; Abrams MJ; Henson G; Gutierrez A; Clotet B; Schols D
    Mol Pharmacol; 1999 Jan; 55(1):67-73. PubMed ID: 9882699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of receptor flexibility in binding of cyclam compounds to the chemokine receptor CXCR4.
    Lam AR; Bhattacharya S; Patel K; Hall SE; Mao A; Vaidehi N
    J Chem Inf Model; 2011 Jan; 51(1):139-47. PubMed ID: 21158459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.
    Ross A; Soares DC; Covelli D; Pannecouque C; Budd L; Collins A; Robertson N; Parsons S; De Clercq E; Kennepohl P; Sadler PJ
    Inorg Chem; 2010 Feb; 49(3):1122-32. PubMed ID: 20039648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme.
    Hunter TM; McNae IW; Liang X; Bella J; Parsons S; Walkinshaw MD; Sadler PJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2288-92. PubMed ID: 15701702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
    Hatse S; Princen K; Gerlach LO; Bridger G; Henson G; De Clercq E; Schwartz TW; Schols D
    Mol Pharmacol; 2001 Jul; 60(1):164-73. PubMed ID: 11408611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
    J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.
    Schols D; Struyf S; Van Damme J; Esté JA; Henson G; De Clercq E
    J Exp Med; 1997 Oct; 186(8):1383-8. PubMed ID: 9334378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and dynamics of metallomacrocycles: recognition of zinc xylyl-bicyclam by an HIV coreceptor.
    Liang X; Parkinson JA; Weishäupl M; Gould RO; Paisey SJ; Park HS; Hunter TM; Blindauer CA; Parsons S; Sadler PJ
    J Am Chem Soc; 2002 Aug; 124(31):9105-12. PubMed ID: 12149014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor.
    Gerlach LO; Jakobsen JS; Jensen KP; Rosenkilde MR; Skerlj RT; Ryde U; Bridger GJ; Schwartz TW
    Biochemistry; 2003 Jan; 42(3):710-7. PubMed ID: 12534283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.